EMD-28190
SARS-CoV-2 RBD in complex with biparatopic nanobody BP10 local refinement
EMD-28190
Single-particle3.89 Å
Deposition: 19/09/2022Map released: 28/12/2022
Last modified: 28/12/2022
Sample Organism:
Severe acute respiratory syndrome coronavirus 2,
Vicugna pacos
Sample: SARS-CoV-2 Spike in complex with biparatopic nanobody BP10
Deposition Authors: Pymm PG, Glukhova A
,
Tham WH
Sample: SARS-CoV-2 Spike in complex with biparatopic nanobody BP10
Deposition Authors: Pymm PG, Glukhova A
,
Tham WH
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2.
Pymm P,
Redmond SJ,
Dolezal O ,
Mordant F,
Lopez E ,
Cooney JP,
Davidson KC,
Haycroft ER ,
Tan CW,
Seneviratna R,
Grimley SL,
Purcell DFJ,
Kent SJ,
Wheatley AK,
Wang LF,
Leis A,
Glukhova A ,
Pellegrini M ,
Chung AW ,
Subbarao K,
Uldrich AP ,
Tham WH ,
Godfrey DI,
Gherardin NA
(2022) iScience , 25 , 105259 - 105259
,
Mordant F,
Lopez E ,
Cooney JP,
Davidson KC,
Haycroft ER ,
Tan CW,
Seneviratna R,
Grimley SL,
Purcell DFJ,
Kent SJ,
Wheatley AK,
Wang LF,
Leis A,
Glukhova A ,
Pellegrini M ,
Chung AW ,
Subbarao K,
Uldrich AP ,
Tham WH ,
Godfrey DI,
Gherardin NA
(2022) iScience , 25 , 105259 - 105259
Grant Support: